Echtzeit-Bewegungserfassung und visuelles Feedback für das Amputations Gangtraining
Der Effekt einer Echtzeit-2D-Bewegungserfassung und visuelles Feedback-Gangtrainingssysteme auf die Wanderleistung bei Menschen mit einseitiger transfemoraler Amputation
People with transfemoral amputation face challenges such as gait asymmetry, instability, and increased energy consumption due to loss of the knee joint. Because of the loss of proprioceptive feedback from their missing limbs, visual feedback is essential for gait correction. Additionally, current visual feedback systems lack portability, cost-effectiveness, and they fail to provide precise, intuitive feedback on spatiotemporal parameters, joint angles, and both frontal and sagittal plane information, limiting their effectiveness in correcting gait abnormalities.This study aims to investigate whether gait training using a real-time 2D motion capture and visual feedback gait training system (2DMV) can improve the gait biomechanics and psychosocial functions of people with unilateral transfemoral amputation (uTFA). The 2DMV system analyzes spatiotemporal parameters and joint kinematics during gait and displays the uTFA's image on a screen, providing visual feedback specifically targeting gait abnormalities. This allows individuals with uTFA to intuitively understand the feedback and make real-time gait adjustments. The biomechanical parameters include joint kinematics, gait symmetry, and walking performance.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Hui-Ting Shih
- Telefonnummer: +886 921 078 256
- E-Mail: huiting.shih@nycu.edu.tw
Studienorte
-
-
-
Taipei, Taiwan, 112
- Rekrutierung
- National Yang Ming Chiao Tung University
-
Kontakt:
- Hui-Ting Shih, PT, PhD
- Telefonnummer: +886-921078256
- E-Mail: huiting.shih@nycu.edu.tw
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age between 18 and 65 years
- Individuals with unilateral transfemoral amputation or knee disarticulation
- Wear a prosthesis for at least 3 hours per day
- Have been using a prosthesis for more than 6 months
- Medicare Functional Classification Level (K-level) of 2 or above
- Able to walk independently for 5 meters without assistive devices
- No pain caused by poor prosthetic fit
- Montreal Cognitive Assessment Taiwan Version (MoCA-T) score ≥ 26
Exclusion Criteria:
- Uncontrolled systemic diseases (e.g., diabetes mellitus, hypertension)
- Cardiopulmonary or cardiovascular diseases (e.g., heart failure, severe asthma)
- History of neurological conditions that affect movement (e.g., stroke, spinal cord injury, cerebellar injury)
- Vestibular disorders
- Severe osteoporosis
- Other musculoskeletal injuries or open wounds
- Epilepsy
- Uncorrected visual impairments
- Congenital limb deficiency
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Real-time 2D motion capture and visual feedback system gait training group (VF)
The VF group, the 2D motion capture and visual feedback training group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of visual feedback gait training using the 2DMV system. |
The difference between the VF group and the PT group lies in the use of real-time visual feedback during gait training; the VF group receives real-time visual feedback, while the PT group undergoes gait training without visual feedback. |
|
Aktiver Komparator: Conventional physical therapy group (PT)
The PT group, the conventional physical therapy group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of gait training without the use of the 2DMV system for visual feedback. During gait training, the therapist provided standard gait correction feedback typically used in conventional physical therapy. |
Ten minutes of strength training followed by thirty minutes of gait training, during which the 2DMV system is not used to provide visual feedback. During the gait training, the therapist provides gait correction feedback typically used in conventional physical therapy. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Step width ratio
Zeitfenster: The step width ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Step width ratio is calculated by dividing step width by pelvis width (step width/pelvis width), and the normal range is between 0.4 to 1.1. |
The step width ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Step length ratio
Zeitfenster: The step length ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Step length ratio is calculated by dividing the step length of the amputated limb by the step length of the non-amputated limb (a value closer to 1 indicate more symmetry, the step length of amputated limb is calculated as the distance between the heel of the non-amputated limb when initial contact and the heel of the amputated limb when initial contact; the step length of non-amputated limb is calculated as the distance between the heel of the amputated limb when initial contact and the heel of the non-amputated limb when initial contact) |
The step length ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Stride time ratio
Zeitfenster: The stride time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Stride time ratio is calculated by dividing the stride time of the amputated limb by the stride time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stride time of the amputated limb is calculated as the time from initial contact of the amputated limb to next initial contact of the same limb; the stride time of the non-amputated limb is calculated as the time from initial contact of the non-amputated limb to next initial contact of the same limb). |
The stride time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Stance time ratio
Zeitfenster: The stance time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Stance time ratio is calculated by dividing the stance time of the amputated limb by the stance time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stance time is calculated from initial contact to toe off of the same limb). |
The stance time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Swing time ratio
Zeitfenster: The swing time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Swing time ratio is calculated by dividing the swing time of the amputated limb by the swing time of the non-amputated limb (a value closer to 1 indicates more symmetry, the swing time is calculated from toe off to initial contact of the same limb). |
The swing time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Hip extension angle
Zeitfenster: The hip extension angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The hip extension angle is measured in the sagittal plane during terminal stance. |
The hip extension angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Hip flexion angle
Zeitfenster: The hip flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The hip flexion angle is measured in the sagittal plane at the maximum angle of hip flexion during the swing phase. |
The hip flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Trunk extension and flexion angle
Zeitfenster: The trunk extension and flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The trunk extension and flexion angle is measured in the sagittal plane at the initial contact and terminal stance. |
The trunk extension and flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Hip adduction and abduction angle
Zeitfenster: The hip adduction and abduction angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The hip adduction and abduction angle is measured in the coronal plane at the maximum angle of hip adduction or abduction angle during the swing phase. |
The hip adduction and abduction angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Horizontal pelvis tilt angle
Zeitfenster: The horizontal pelvis tilt angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The horizontal pelvis tilt angle is measured in the coronal plane at the maximum pelvis tilt angle during single-leg stance. |
The horizontal pelvis tilt angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Trunk lateral flexion angle
Zeitfenster: The trunk lateral flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The trunk lateral flexion angle is measured in the coronal plane during midstance. |
The trunk lateral flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The Component Timed-Up-and-Go test, cTUG
Zeitfenster: The Component Timed-Up-and-Go test will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The participant will first be instructed to sit on a chair with a backrest. When the assessor says 'go,' the participant will stand up, walk forward, circle around a cone, return to the chair, and sit down, all at a self-selected speed. The assessor will time the duration of the entire process. The timing of the Component Timed-Up-and-Go test will be divided into five components: standing up, walking forward, circling around the cone, walking back to the chair, and sitting down. Time will be measured in seconds. |
The Component Timed-Up-and-Go test will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
Gait speed
Zeitfenster: The gait speed will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
Gait speed will be measured by the assessor with a timer. The participant will be instructed to walk 5 meters at a self-selected speed. The first and last 1 meter will serve as the acceleration and deceleration phases, while the gait speed in middle 3 meters will be measured. Time will be measured in seconds. |
The gait speed will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
The Activities-specific Balance Confidence Scale, ABC scale
Zeitfenster: The Activities-specific Balance Confidence Scale will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
The Activities-specific Balance Confidence Scale is a self-reported questionnaire used to assess balance confidence. Scores range from 0% to 100%, with higher scores indicating greater confidence. The scale consists of 16 items in total. |
The Activities-specific Balance Confidence Scale will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.
|
|
The National Aeronautics and Space Administration Task Load Index, NASA-TLX
Zeitfenster: The National Aeronautics and Space Administration Task Load Index will be measured after the 12th intervention session.
|
The National Aeronautics and Space Administration Task Load Index is a self-repoted scale, totally has 6 items, including mental demand, physical demand, temporal demand, performance, effort, and frustration. The score will recorded as 0 to 100, with the higher score indicating higher work load. |
The National Aeronautics and Space Administration Task Load Index will be measured after the 12th intervention session.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- NYCU114067AE
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .